CONGRESS

SOLACI is the reference organization for Latin American cardiovascular interventionism.

Last News

Inflammation after TAVI: An Emerging Therapeutic Target?

Dr. Juan Manuel Pérez - 22 June, 2026 0

Conduction disturbances and the need for permanent pacemaker implantation remain common complications following TAVI, with an incidence approaching 15%. Although they have traditionally been...

SPYRAL Program: 3-Year Outcomes in Patients Treated with Renal Denervation

Dr. Andrés Rodríguez - 19 June, 2026 0

Hypertension is the leading modifiable risk factor for cardiovascular disease and remains a major global health challenge, affecting more than one billion adults worldwide. Despite...

Coronary Obstruction During TAVI: A New Volumetric Index to Consider

Dr. Omar Tupayachi - 17 June, 2026 0

Coronary obstruction during TAVI is an uncommon but potentially catastrophic complication, particularly in valve-in-valve procedures, in anatomies with small sinuses of Valsalva, low coronary...

Access

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Terms of Use - Privacy Policy.

ADAPT-DES: Results at 1 year of the clinical impact of hypo-responders to aspirin and clopidogrel.

POST trial: Post-conditioning effect in myocardial reperfusion with primary angioplasty.

STEMI RADIAL A prospective, randomized trial which compares radial versus femoral access in patients with ST- segment elevation acute myocardial infarction.

ISAR-DESIRE 3: A paclitaxel eluting balloon versus Taxus in the treatment of eluting stent restenosis.

MASTER Trial: Prospective, multicentre, randomized trial evaluating the MGuard stent in the treatment of patients with acute myocardial infarction with ST segment elevation (STEMI).

PARTNER cohort B: Clinical events at 3 years follow-up in patients with

ETAP: Endovascular treatment of atherosclerotic popliteal artery lesions: a prospective, multi-center, randomized study.

ISAR-LEFT MAIN 2: Everolimus-eluting stents versus Zotarolimus eluting stents in the treatment of the unprotected left coronary trunk.

Last News

Inflammation after TAVI: An Emerging Therapeutic Target?

SPYRAL Program: 3-Year Outcomes in Patients Treated with Renal Denervation

Coronary Obstruction During TAVI: A New Volumetric Index to Consider

Institutional News

Fellow’s Corner – Case 2: Acute Myocardial Infarction Due to Simultaneous Occlusion of Two Coronary Arteries

V International Course on Cardiovascular Interventionism – SOLACI Scientific Endorsement

Guatemala Sessions 2026 – Young Interventional Cardiologists Contest – Submit Your Case

Access